Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cadonilimab”

139 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 139 results

Testing effectiveness (Phase 2)Looking for participantsNCT06383533
What this trial is testing

Disitamab Vedotin Plus Cadonilimab in Patients With HER2 Mutant Advanced or Metastatic Bile Duct Adenocarcinoma

Who this might be right for
Bile Duct Adenocarcinoma Non-ResectableHER2 Gene Mutation
Zhejiang Cancer Hospital 28
Testing effectiveness (Phase 2)Active Not RecruitingNCT05063916
What this trial is testing

Phase II Study of AK104 (Cadonilimab) for Recurrent Small Cell Neuroendocrine Carcinomas of the Cervix

Who this might be right for
CarcinomasCervix CancerCervical Cancer
M.D. Anderson Cancer Center 18
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05833971
What this trial is testing

Cadonilimab in Combination With Chemotherapy for Locally Advaced Esophageal Squamous Cell Carcinoma

Who this might be right for
Resectable Esophageal Squamous Cell CarcinomaNeoadjuvant Therapy
Guangzhou Institute of Respiratory Disease 43
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06492317
What this trial is testing

RC48 Plus AK104 as First-line Treatment for HER2-overexpressing Advanced Gastric Cancer

Who this might be right for
HER2-positive Gastric Cancer
The First Affiliated Hospital of Zhengzhou University 20
Testing effectiveness (Phase 2)UnknownNCT05790200
What this trial is testing

Cadonilimab (AK104) in the Treatment of Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06586294
What this trial is testing

Anti-PD-1 and LAG-3 Bispecific Antibody(AK129) Combined With Chemotherapy With or Without Cadonilimab in the First-line Treatment of Unresectable Locally Advanced or Metastatic G/ GEJ Adenocarcinoma

Who this might be right for
Gastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma
Akeso 294
Testing effectiveness (Phase 2)Looking for participantsNCT06494995
What this trial is testing

AK104 and Low-dose Radiation in Recurrent/Metastatic HNSCC After Failure of First-line Systemic Therapy

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Fudan University 52
Not applicableNot Yet RecruitingNCT06155422
What this trial is testing

A Prospective Real-world Study of Cadonilimab in Patients With Recurrent or Metastatic Cervical Cancer

Who this might be right for
Recurrent or Metastatic Cervical Cancer
Gang Chen (101199) 670
Large-scale testing (Phase 3)Active Not RecruitingNCT05941741
What this trial is testing

IC Plus Low-dose Radiation Plus Cadonilimab in LANPC

Who this might be right for
Nasopharyngeal CarcinomaImmune Checkpoint InhibitorRadiotherapy+1 more
Sun Yat-sen University 380
Testing effectiveness (Phase 2)UnknownNCT05990231
What this trial is testing

Cadonilimab/Anlotinib in Locally Advanced or Relapsed/Metastatic ESCC Patients After Failure of PD-1 Combined With Platinum-containing Chemotherapy

Who this might be right for
Esophageal Squamous Cell Carcinoma
Second Affiliated Hospital, School of Medicine, Zhejiang University 35
Testing effectiveness (Phase 2)Looking for participantsNCT06406634
What this trial is testing

Cadonilimab in Combination With Lenvatinib and Hepatic Arterial Infusion Chemotherapy (HAIC) for the Treatment of Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Hunan Cancer Hospital 30
Testing effectiveness (Phase 2)UnknownNCT05915481
What this trial is testing

Stereotactic Body Radiotherapy Combined With Cadonilimab for Advanced Refractory Malignant Solid Tumors

Who this might be right for
Advanced Solid TumorStereotactic Body RadiotherapyImmune Checkpoint Inhibitor+2 more
Peking University Third Hospital 60
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06196775
What this trial is testing

Cadonilimab Combined With AK112 as Second-line Therapy in Patients With Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Harbin Medical University 36
Not applicableLooking for participantsNCT06551207
What this trial is testing

Cadonilimab Combined With Fruquintinib and SBRT as Athird-line and Posterior Line Treatment in Patients With MSS CRC

Who this might be right for
Metastatic Colorectal Cancer
Liu Huang 80
Testing effectiveness (Phase 2)Looking for participantsNCT06438822
What this trial is testing

Cadonilimab Combined With Liposomal Irinotecan Plus Leucovorin and Fluorouracil for Advanced Cholangiocarcinoma

Who this might be right for
Cholangiocarcinoma
West China Hospital 51
Testing effectiveness (Phase 2)Looking for participantsNCT06168786
What this trial is testing

Cadonilimab Combined With Fruquintinib and SBRT as Athird-line and Posterior Line Treatment in Patients With MSS CRC

Who this might be right for
Colorectal Cancer
Huazhong University of Science and Technology 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05784974
What this trial is testing

Cadonilimab Monotherapy as Neoadjuvant Therapy for Resectable II-IIIA Squamous Cell Lung Cancer

Who this might be right for
Lung Cancer
The First Hospital of Jilin University 37
Testing effectiveness (Phase 2)Looking for participantsNCT06654011
What this trial is testing

IN10018 With Nab-Paclitaxel and Cadonilimab for Metastatic or Recurrent Gastric-Type Cervical Adenocarcinoma: Phase 2 Trial

Who this might be right for
Cervical AdenocarcinomaGastric-type Endocervical Adenocarcinoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 25
Testing effectiveness (Phase 2)Active Not RecruitingNCT06448910
What this trial is testing

Cadonilimab(AK104) Plus Concurrent Chemoradiotherapy in Patients With Locally Advanced, Unresectable, Stage III NSCLC

Who this might be right for
NSCLCLocally Advanced Lung Carcinoma
Fudan University 41
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06202313
What this trial is testing

Study of Cadonilimab (AK104) Plus Eribulin vs. Eribulin Monotherapy for Recurrent or Metastatic Triple-negative Breast Cancer

Who this might be right for
Triple Negative Breast Cancer
Shengjing Hospital 128
Load More Results